Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Protagen Protein Services Merges with GeneWerk to Integrate Leading Protein and Gene Therapy Analytic Platforms
Protagen Protein Services (PPS) today announced that it will merge with GeneWerk, an Ampersand portfolio […]
Clinical Research Practitioners (CRPs) Sign Up to New Accredited Register
The National Institute for Health Research (NIHR) has announced the launch of a new professional […]
Oncodesign, Covalab, CheMatech and ABX-CRO Launch DRIVE™-MRT, a Premium Complete, Integrated Service Offer for Radiopharmaceuticals Drug Discovery and Generation
ONCODESIGN (ALONC -FR0011766229), a French biopharmaceutical company dedicated to precision medicine, Covalab (Bron, France), a biotechnology company specializing […]
Doctrin Raises €13 Million to Accelerate International Expansion
Swedish health tech company Doctrin raises €13 million to fuel further expansion. The round is led by […]
SCAS CPR Resuscitation and Defibrillator App Save a Life Sees Spike in Downloads
An ambulance service app which provides cardiopulmonary resuscitation (CPR) guidance and locates the nearest defibrillator […]
WHO/Europe Launches New Monitoring Tool, Tracking Rates of COVID-19 in UEFA Euro 2020 Host Cities
With the UEFA European Football Championships being played in cities across the WHO European Region, […]
Largest Robotic Surgery Programme in UK to Tackle COVID Backlog
Guy’s and St Thomas‘ has taken delivery of a new surgical robot to help speed […]
ReStart and Better Announce a Partnership to Improve Data Interoperability Within the NHS
ReStart and Better have signed a partnership agreement to improve interoperability between NHS organisations, regardless of […]
AWS Announces AWS Healthcare Accelerator for Startups in the Public Sector
The healthcare industry is currently experiencing seismic shifts with much of the focus being placed […]
Intranasal COVID-19 Vaccine Demonstrates Single-dose Efficacy in Preclinical Studies, in Parallel with Achievement of Phase 1 Clinical Milestone
Codagenix Inc., a clinical-stage synthetic biology company pioneering a novel platform for vaccines and oncolytic […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more